Research in animal models shows combined use produces 30% faster healing with enhanced fibroblast activity and immune cell migration
Levocarnitine is an amino-acid derivative essential for mitochondrial fatty-acid transport, and this injectable formulation is used to treat or prevent clinically significant carnitine deficiency in conditions such as primary systemic carnitine deficiency, certain inborn errors of metabolism, and end-stage renal disease on dialysis
In other embodiments, PLGA copolymers with polyethylene glycol (PEG) are suitable polymeric matrices for the formulations disclosed herein
In the UK, adults with confirmed B12 deficiency and neurological symptoms typically receive hydroxocobalamin injections1 mg intramuscularly on alternate days until symptoms stabilise, followed by maintenance doses every two months
Press and hold the button below to confirm
In some embodiments, the auris-acceptable formulations or compositions described herein are gel formulations or gel compositions